WellSpring, a Sarasota, Florida-based provider of over-the-counter and personal care solutions, has announced the acquisition of skin care brands DerMend and Recticare. This strategic move is backed by Avista, positioning WellSpring to expand its portfolio in the healthcare and dermatology markets. The acquisition of DerMend and Recticare significantly enhances WellSpring's product offerings. DerMend specializes in dermatological solutions for aging skin, while Recticare focuses on anorectal care products.

This expansion allows WellSpring to address a broader range of consumer health needs, leveraging the established reputations of these brands. For Avista, this deal represents a continued investment strategy in the consumer health sector. The implications for the industry include potential shifts in market share and increased competition among OTC providers. WellSpring is likely to integrate these brands into its existing distribution channels, driving growth and accessibility.

Stakeholders, including healthcare providers and distributors, may see new product availability. This acquisition underscores the ongoing consolidation trend within the personal care industry, driven by private equity interest.